BENZENO SHARON (Sr VP, Drug Discovery) sold 18.8% of their position (63.10K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $831.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2026ACC: 0001780854-26-000004
Officer· Sr VP, Drug Discovery
Since Jun 2019
-63.10K
Net shares
Net seller
$831.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
63.10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−63.10K
Price / share
$13.17
Trade value
$831.07K
% of position
18.8%
3/11/2026
335.85K→272.75K
Total
Net shares
−63.10K
Net value
-$831.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −63.10K | $13.17 | $831.07K | 18.8% | 335.85K | 272.75K |
| Total | −63.10K | -$831.07K | ||||||
Derivative Transactions0
No derivative transactions reported